research Archives - MedEngine

Expert Profile

Marrying medical consultancy and the academic world

With the acquisition of ApHER, the Institute of Applied Economics & Health Research, we’re happy to welcome a number of new co-workers. This time in…

Klaus Elfving16/11/2021

In Press

In Press: New study estimates over nine million people living with type 1 diabetes

A study published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), estimates the prevalence of people living with type…

MedEngine05/10/2021

In Press

In Press: In Finland haemophilia quality of care is high and has reasonable costs

Finnish Haemophilia patients have comprehensive followup and most receive factor replacement therapy, shows the results from the HemoHEOR study which was published this week in…

Aino Vesikansa23/11/2020

In Press

In Press: Obesity is associated with poor quality of life and working ability among Finnish adults

Obesity has a significant negative impact on quality of life (QoL) and perceived physical and psychological working ability. This summarizes the first results of the…

Aino Vesikansa06/11/2020

Haemophilia treatment in Finnish university hospitals

In Press

In Press: Clinical practice and treatment costs of haemophilia in Finland

Haemophilia treatment in Finnish university hospitals is of excellent quality and at costs reasonable within European standards, shows the HemoHEOR study conducted by MedEngine that…

MedEngine15/01/2020

In Press

In Press: Early start of anti-dementia medication reduces the risk of death in Alzheimer’s disease

A real-world registry study, recently accepted for publication in the Journal of Alzheimer’s Disease, demonstrates an association between the early initiation of anti-dementia medication and…

Inkeri Spoljaric19/09/2019

In Press

In Press: Real-world treatment outcomes of vedolizumab among Finnish IBD patients (FINVEDO)

A recently published real-world cohort study demonstrated that vedolizumab, an anti-integrin antibody, is an effective and well-tolerated treatment option for patients with inflammatory bowel disease (IBD). The…

Anna Grönholm01/02/2018

Insight

MedEngine presented results from three new studies at the ISPOR congress in Glasgow

The 20th Annual European Congress of The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) was held in Glasgow, Scotland on Nov 4–8th 2017. The event attracted…

Tero Ylisaukko-oja30/11/2017

Insight

Beyond treating patients: Secondary uses of health and social data

Whether it be an encounter with a physician or nurse, a prescription for medication from a pharmacy, or admittance of a student loan—every contact that…

MedEngine20/09/2017

Marrying medical consultancy and the academic world

In Press: New study estimates over nine million people living with type 1 diabetes

In Press: In Finland haemophilia quality of care is high and has reasonable costs

In Press: Obesity is associated with poor quality of life and working ability among Finnish adults

In Press: Clinical practice and treatment costs of haemophilia in Finland

In Press: Early start of anti-dementia medication reduces the risk of death in Alzheimer’s disease

In Press: Real-world treatment outcomes of vedolizumab among Finnish IBD patients (FINVEDO)

MedEngine presented results from three new studies at the ISPOR congress in Glasgow

Beyond treating patients: Secondary uses of health and social data

Recent Posts

Get in Touch

Find Us

Sign up for our newsletter